Henry Schein, Inc.
- Jurisdiction
United States - LEI
VGO3WGL8H45T73F4RR92 - ISIN
US8064071025 (HSIC )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€76.53 37.9% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. Read full profile
Fundamentals
- Net revenue
€10.89B - Gross margin
30.8% - EBIT
€563.80M - EBIT margin
5.2% - Net income
€331.80M - Net margin
3.0%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| DANIEL WILLIAM K | N/A |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Julie Johnson | May 14, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | May 8, 2025 | $1.00K–$15.00K |
| Gilbert Cisneros | April 7, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Ray Dalio |
|
|
|
Sell |